Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial

Peer Review reports

Original Submission
27 Oct 2017	Submitted	Original manuscript
3 Dec 2017	Reviewed	Reviewer Report - Pedro Inacio
18 Dec 2017	Reviewed	Reviewer Report - Linda Harmark
25 Jan 2018	Author responded	Author comments - Gilles Defer
Resubmission - Version 2
25 Jan 2018	Submitted	Manuscript version 2
5 Feb 2018	Reviewed	Reviewer Report - Pedro Inacio
23 Feb 2018	Author responded	Author comments - Gilles Defer
Resubmission - Version 3
23 Feb 2018	Submitted	Manuscript version 3
Publishing
26 Feb 2018	Editorially accepted
9 Mar 2018	Article published	10.1186/s13063-018-2560-4

Back to article page